RESUMEN
OBJECTIVE: To provide practical recommendations for the comprehensive approach of people with type 2 diabetes according to evidence-based medicine. PARTICIPANTS: Members of the Diabetes Knowledge Area of the Spanish Society of Endocrinology and Nutrition. METHODS: The recommendations were formulated according to the degrees of evidence of the Standards of Medical Care in Diabetes-2022. After reviewing the available evidence and formulating recommendations by the authors of each section, several rounds of comments were developed incorporating the contributions and voting on controversial points. Finally, the final document was sent to the rest of the members of the area for review and incorporation of contributions, to finally carry out the same process with the members of the Spanish Society of Endocrinology and Nutrition Board of Directors. CONCLUSIONS: The document establishes practical recommendations based on the latest available evidence for the management of people with type 2 diabetes.
Asunto(s)
Diabetes Mellitus Tipo 2 , Humanos , Diabetes Mellitus Tipo 2/terapia , Sociedades Médicas , EspañaRESUMEN
Diabetes mellitus type 2 (T2DM) is a global pandemic that will affect 300 million people in the next decade. It has been shown that early and aggressive treatment of T2DM from the onset decreases complications, and the patient's active role is necessary to achieve better glycemic control. In order to achieve glycemic control targets, an active attitude in patients is needed, and self-monitoring of blood glucose (SMBG) plays a significant role. Nowadays, SMBG has become an important component of modern therapy for diabetes mellitus, and is even more useful if it is performed in a structured way. SMBG aids physicians and patients to achieve a specific level of glycemic control and to prevent hypoglycemia. In addition, SMBG empowers patients to achieve nutritional and physical activity goals, and helps physicians to optimize the different hypoglycemic therapies as demonstrated in the St Carlos study. This article describes the different ways of using this educational and therapeutic tool from the medical point of view as well as from the patient's perspective.
Asunto(s)
Diabetes Gestacional/diagnóstico , Guías de Práctica Clínica como Asunto , Glucemia/análisis , Estudios de Cohortes , Análisis Costo-Beneficio , Diabetes Gestacional/economía , Diabetes Gestacional/epidemiología , Diabetes Gestacional/terapia , Femenino , Prueba de Tolerancia a la Glucosa/economía , Humanos , Recién Nacido , Tamizaje Masivo , Embarazo , Resultado del Embarazo , Estándares de Referencia , Factores de Riesgo , España/epidemiologíaRESUMEN
No disponible
Asunto(s)
Femenino , Humanos , Embarazo , Diabetes Gestacional/diagnóstico , Prueba de Tolerancia a la Glucosa , Biomarcadores/análisis , Factores de Riesgo , Complicaciones del Embarazo/diagnósticoRESUMEN
No disponible